Phase Ii/Iii Study Of Sm-88 In Patients With Metastatic Pancreatic Cancer

Vincent Chung,Sant P. Chawla, Huan Dong,Semmie Kim,Ronald Lee Korn,Kian-Huat Lim,Marcus Smith Noel,Anne M. Noonan,Paul Eliezer Oberstein,Allyson J. Ocean,Shubham Pant,Vincent J. Picozzi,Philip Agop Philip,Alexander Rosemurgy,Benjamin R. Tan,Andrea Wang-Gillam,Steve Wong,Giuseppe Del Priore

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 4|浏览8

暂无评分

摘要

437Background: SM-88 (racemetyrosine, Tyme Inc) is a dysfunctional tyrosine derivative used with MPS (methoxsalen 10mg, phenytoin 50mg and sirolimus 0.5mg). SM-88 was well tolerated with improvemen...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要